Sojiro Morita
Kochi, 7818555, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Possibility of Neoadjuvant Treatment for Radiologically Judged Resectable Pancreatic Cancer.
Journal: Journal of clinical medicine
Published: October 24, 2022
Preoperative percent body fat in bioelectrical impedance analysis predicts pancreatic fistula after pancreaticoduodenectomy.
Journal: Langenbeck's archives of surgery
Published: October 18, 2022
A proposal to modify the 8th edition of the UICC staging system for pancreatic adenocarcinoma.
Journal: Langenbeck's archives of surgery
Published: October 26, 2020
Indications for pancreaticoduodenectomy affected postoperative outcomes in octogenarians.
Journal: Annals of gastroenterological surgery
Published: June 03, 2020
Feasibility of preserving the remnant stomach during distal pancreatectomy after distal gastrectomy.
Feasibility of preserving the remnant stomach during distal pancreatectomy after distal gastrectomy.
Journal: Surgery today
Published: February 17, 2020
Effect of Neoadjuvant Chemotherapy in Patients with Colorectal Cancer Liver Metastases.
Journal: Surgical technology international
Published: May 01, 2019
Clinicopathologic Features and Surgical Outcomes of Neuroendocrine Carcinoma of the Gallbladder.
Journal: Surgical technology international
Published: March 20, 2019
l-Carnitine Improves Postoperative Liver Function in Hepatectomized Patients.
Journal: JPEN. Journal of parenteral and enteral nutrition
Published: March 14, 2019
Liver fibrosis assessment using 99mTc-GSA SPECT/CT fusion imaging.
Journal: Japanese journal of radiology
Published: December 04, 2018
A Surgical Case of Inferior Mesenteric Arteriovenous Malformation.
Journal: Surgical technology international
Published: October 03, 2018
Preoperative neutrophili-to-lymphocyte ratio is useful for stratifying the prognosis of tumor markers-negative pancreatic cancer patients.
Journal: American journal of surgery
Published: October 01, 2018
Phase I/II study of first-line combination therapy with sorafenib plus resminostat, an oral HDAC inhibitor, versus sorafenib monotherapy for advanced hepatocellular carcinoma in east Asian patients.
Journal: Investigational new drugs
Published: June 29, 2018
Last Updated: 09/26/2026